Late-breaking Phase III data show ianalumab, Novartis’ dual-targeted antibody, reduced disease activity and patient burden in ...
15h
A newly-discovered mechanism could contribute to the therapeutic effects of deep brain stimulation
Deep brain stimulation (DBS) is a surgical procedure that entails the delivery of high-frequency electrical impulses to ...
The findings confirm that allosteric inhibition of integrase is clinically viable, validating a new antiviral drug class.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback